Kurarinone's Effects on EAE in Mice through Gut Microbiota Modulation
In mice, Kurarinone was shown to reduce the severity of experimental autoimmune encephalomyelitis (EAE) by enhancing the gut bacteria Akkermansia muciniphila. Additionally, levels of a metabolite called Indole-3-acetaldehyde (IAAld) were correlated with both the abundance of Akkermansia and lower EAE severity, while IAAld treatment led to a decrease in harmful immune cell types.
- Tags
- #Other
- Most relevant to
- —
- Human efficacy
- Not yet assessed
- Mechanism
- Not yet assessed
- Evidence strength
- Not yet assessed
- Outcome
- Not yet assessed
Why it matters
These findings suggest a potential connection between gut microbiota and immune regulation in EAE, which may inform future research into MS therapies targeting gut health.
What this does not prove
The study does not provide direct evidence of Kurarinone's therapeutic effects in humans, and the metabolic mechanisms observed may not fully apply to human physiology.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Yes
- Relevant MS type
- Not reported
- Publication date
- 2026-10-15
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Other
Original sources
- Primary evidenceGut Microbiota-Derived Indole-3-Acetaldehyde Contributes to the Disease-Alleviating Effects of Kurarinone in Experimental Autoimmune Encephalomyelitis. ↗DOI: 10.1002/advs.78358
Supporting passages (10)
study phaseHere, we demonstrate that KU ameliorates experimental autoimmune encephalomyelitis (EAE)-an animal model of MS-by modulating the gut microbiota, particularly via enriching Akkermansia muciniphila, and A.
subjectsHere, we demonstrate that KU ameliorates experimental autoimmune encephalomyelitis (EAE)-an animal model of MS-by modulating the gut microbiota, particularly via enriching Akkermansia muciniphila, and A.
speciesHere, we demonstrate that KU ameliorates experimental autoimmune encephalomyelitis (EAE)-an animal model of MS-by modulating the gut microbiota, particularly via enriching Akkermansia muciniphila, and A.
peer reviewedCollectively, this study identifies a novel mechanism by which KU mitigates EAE via the gut metabolite IAAld-AhR-immune axis and unveils potential therapeutic targets for MS.
primary endpoint metIAAld treatment ameliorates EAE and reduces the frequencies of pathogenic Th1 and Th17 cells in mice.
research categoriesHere, we demonstrate that KU ameliorates experimental autoimmune encephalomyelitis (EAE)-an animal model of MS-by modulating the gut microbiota, particularly via enriching Akkermansia muciniphila, and A.
publication date2026-10-15
primary endpointHere, we demonstrate that KU ameliorates experimental autoimmune encephalomyelitis (EAE)-an animal model of MS-by modulating the gut microbiota, particularly via enriching Akkermansia muciniphila, and A.
findingsHere, we demonstrate that KU ameliorates experimental autoimmune encephalomyelitis (EAE)-an animal model of MS-by modulating the gut microbiota, particularly via enriching Akkermansia muciniphila, and A.
limitationsTitle: Gut Microbiota-Derived Indole-3-Acetaldehyde Contributes to the Disease-Alleviating Effects of Kurarinone in Experimental Autoimmune Encephalomyelitis.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.